aa
Home
Sitemap
Contact Us
HOME
ABOUT
Aims and Scope
About the KJM
General Information
Editorial Board
Best Pracitce
Open Access
Contact us
BROWSE ARTICLES
All issues
Accepted Articles
Ahead-of Print Articles
Current Issue
Most Read Articles
Most Cited Articles
Korean J Med
Search
Author Index
EDITORIAL POLICY
Research and Publication Ethics
Peer Review Policy
Preprints Policy
Advertising Policy
Data Archiving Policy
Data Sharing Policy
FOR CONTRIBUTORS
Instructions for Authors
Copyright Transfer Agreements
Article-processing Charge
E-Submission
Search
Korean J Med
Search
Page Path
HOME
BROWSE ARTICLES
Search
Roadmap to final diagnosis
혈액종양의 세계보건기구 분류에 근거한 급성골수성백혈병의 진단적 접근
Young-Uk Cho
Korean J Med.
2022;97(5):308-318.
Published online October 1, 2022
DOI:
https://doi.org/10.3904/kjm.2022.97.5.308
Cited By 1
Full text
PubReader
ePub
PDF
Hemato-oncology / Case Report
[English]
CD19 양성 혼합
표현형
급성백혈병의 블리나투모맙 치료 1예
Young Hoon Park, Dong Jin Park
Korean J Med.
2022;97(1):60-63.
Published online February 1, 2022
DOI:
https://doi.org/10.3904/kjm.2022.97.1.60
Full text
PubReader
ePub
PDF
Special Review
중증 천식의 임상적, 병태생리적 특징
Sang-Heon Kim
Korean J Med.
2012;83(4):424-429.
Published online October 1, 2012
DOI:
https://doi.org/10.3904/kjm.2012.83.4.424
Cited By 1
Full text
PubReader
ePub
PDF
1
Korean Journal
of Medicine
Print ISSN: 1738-9364
Online ISSN: 2289-0769
MOST VIEWED
MOST CITED
23,164
Review of Antibody-Drug Conjugates
8,876
Diagnosis and Treatment of Premature Atrial or Ventricular Complexes
10,089
Updated Guidelines for Acute Respiratory Distress Syndrome
8,250
Core Elements for Implementing Antimicrobial Stewardship Programs in Korean General Hospitals
12,570
New Guidelines for Idiopathic Pulmonary Fibrosis and Progressive Pulmonary Fibrosis
+more
Cited By
1
Non-face-to-face Treatment in Korea: Suggestions for Essential Conditions
Cited By
1
Interpretation of Estimated Glomerular Filtration Rate
Cited By
1
The First Step in Resolving Medical Disputes Involving Physicians of South Korea: Fair Medical Appraisal
Cited By
1
SGLT2 Inhibitors: Emerging Drugs in Heart Failure
Cited By
1
Non-invasive Evaluation of Liver Fibrosis
+more